Clinical Trial Update: Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment [Phase 1]

View source ↗

Summary

A Phase 1 safety study of the investigational drug MM-151 in patients with advanced solid tumors that have resisted standard treatment has completed. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck
• Triple-negative Breast Cancer

Drugs mentioned

• MM-151

Snippet

Sponsor: Merrimack Pharmaceuticals | Conditions: Advanced Solid Tumors, Colorectal Cancer | Phase 1 | Status: COMPLETED